FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1740-1745 April 22, 2004 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The outbreak of severe acute respiratory syndrome (SARS) in Singapore ended in late May 2003.¹ The Centers for Disease Control and Prevention (CDC) removed its travel alerts for Toronto, Hong Kong, China, and Taiwan shortly thereafter.² We report the first case of SARS to occur in Singapore after the initial worldwide outbreak ended. Our report documents the transmission of SARS in a laboratory setting.

Case Report

A 27-year-old graduate student in microbiology at a local university was admitted to Singapore General Hospital on September 3, 2003, with fever. In July and August 2003, he had worked with a nonattenuated strain of West . . . [Full Text of this Article]

Methods

Epidemiologic Investigations

Laboratory Investigations

Nucleic Acid Extraction

RT-PCR

Serologic Analysis

Viral Culture

Sequence Analysis of the SARS-CoV Viral Genome

Results

Epidemiologic Investigations

PCR, Serologic Analyses, and Viral Culture

Genome Sequence Analysis of SARS-CoV from the Patient

Discussion

Source Information

From the Department of Infectious Diseases, Tan Tock Seng Hospital (P.L.L., B.A., Y.-S.L.); the Departments of Medicine (A.K.) and Pathology (K.P.C., S.Y.S-T., L.O., X.B.), Singapore General Hospital; the Ministry of Health (G.G., L.J., P.L.O., C.S.K.); the Genome Institute of Singapore (C.W.W., L.W.S., Y.R., L.D.M., V.B.V.); and DSO National Laboratories (L.C.N.) — all in Singapore; and the International Emerging Infections Program, Centers for Disease Control and Prevention, Nonthaburi, Thailand (S.J.O.).

Address reprint requests to Dr. Lim at the Department of Infectious Diseases, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, or at pllim@post.harvard.edu.

This article has been cited by other articles:

• Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., Baric, R. (2008). Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge. J. Virol. 82: 3220-3235 [Abstract] [Full Text]  
• Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., Yuen, K. Y. (2007). Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clin. Microbiol. Rev. 20: 660-694 [Abstract] [Full Text]  
• Madjid, M., Luepker, R. V., Greenlund, K. J., Taubert, K. A., Roy, M. J., Robertson, R. M. (2007). Task Force IV: Cardiovascular Effects of Emerging Infectious Diseases and Biological Terrorism Threats: Basic, Clinical, and Population Science Research and Training Needs. J Am Coll Cardiol 49: 1407-1412 [Full Text]  
• Li, W., Wong, S.-K., Li, F., Kuhn, J. H., Huang, I-C., Choe, H., Farzan, M. (2006). Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions. J. Virol. 80: 4211-4219 [Full Text]  
• Mahony, J. B., Richardson, S. (2005). Molecular Diagnosis of Severe Acute Respiratory Syndrome: The State of the Art. J. Mol. Diagn. 7: 551-559 [Abstract] [Full Text]  
• Yu, F., Le, M. Q., Inoue, S., Thai, H. T. C., Hasebe, F., del Carmen Parquet, M., Morita, K. (2005). Evaluation of Inapparent Nosocomial Severe Acute Respiratory Syndrome Coronavirus Infection in Vietnam by Use of Highly Specific Recombinant Truncated Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay. CVI 12: 848-854 [Abstract] [Full Text]  
• Sui, J., Li, W., Roberts, A., Matthews, L. J., Murakami, A., Vogel, L., Wong, S. K., Subbarao, K., Farzan, M., Marasco, W. A. (2005). Evaluation of Human Monoclonal Antibody 80R for Immunoprophylaxis of Severe Acute Respiratory Syndrome by an Animal Study, Epitope Mapping, and Analysis of Spike Variants. J. Virol. 79: 5900-5906 [Abstract] [Full Text]  
• Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., He, T., Yu, W., Yu, J., Gao, H., Tu, X., Gettie, A., Farzan, M., Yuen, K.-y., Ho, D. D. (2005). Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region. J. Virol. 79: 2678-2688 [Abstract] [Full Text]  
• Levy, M. M., Baylor, M. S., Bernard, G. R., Fowler, R., Franks, T. J., Hayden, F. G., Helfand, R., Lapinsky, S. E., Martin, T. R., Niederman, M. S., Rubenfeld, G. D., Slutsky, A. S., Stewart, T. E., Styrt, B. A., Thompson, B. T., Harabin, A. L. (2005). Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome. Am. J. Respir. Crit. Care Med. 171: 518-526 [Abstract] [Full Text]  
• Jernigan, J. A., Helfand, R. F., Parashar, U. D. (2004). Accurate Clinical Prediction of Severe Acute Respiratory Syndrome: Are We There Yet?. ANN INTERN MED 141: 396-398 [Full Text]  
• (2004). SARS: Airborne Transmission and Laboratory Acquisition. JWatch Infect. Diseases 2004: 3-3 [Full Text]